Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.63 |
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | DPYD | Q12882 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.42 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.42 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.42 |
| ▸ | CHAT | P28329 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30533683 | 1.00 | APP (0.63) | APPNFE2L2TRPA1SIGMAR1MAOB | |
| SCHEMBL5574066 | 1.00 | APP (0.63) | APPNFE2L2TRPA1SIGMAR1MAOB | |
| SCHEMBL10454309 | 0.87 | APP (0.57) | APPNFE2L2TRPA1SIGMAR1MEN1 | |
| SCHEMBL700193 | 0.86 | APP (0.65) | APPNFE2L2TRPA1SIGMAR1MAOB | |
| SCHEMBL700192 | 0.86 | APP (0.65) | APPNFE2L2TRPA1SIGMAR1MAOB | |
| SCHEMBL10454313 | 0.85 | NFE2L2 (0.50) | APPNFE2L2TRPA1SIGMAR1MAOB | |
| SCHEMBL28410501 | 0.85 | NFE2L2 (0.50) | APPNFE2L2TRPA1SIGMAR1MAOB | |
| SCHEMBL29049176 | 0.83 | NFE2L2 (0.66) | APPNFE2L2MAOBMAOACASP3 | |
| SCHEMBL29049169 | 0.83 | APP (0.61) | APPNFE2L2TRPA1SIGMAR1KMT2A | |
| SCHEMBL44503 | 0.82 | NFE2L2 (0.68) | NFE2L2TRPA1MAOBCYP19A1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-07-27 | — | — | US | disclosed |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-07-27 | — | — | US | disclosed |
| US-9944826-B2 | Dynamic polymer material for 3D printing | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2018-04-17 | — | — | US | disclosed |
| US-20170204292-A1 | DYNAMIC POLYMER MATERIAL FOR 3D PRINTING | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-07-20 | — | — | US | disclosed |
| EP-1802560-A2 | HALOCOMBSTATINS AND METHODS OF SYNTHESIS THEREOF | Arizona Board Regents, a body corporate of the State of Arizona, acting for and on behalf of Arizona State University (US) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006036743-A2 | HALOCOMBSTATINS AND METHODS OF SYNTHESIS THEREOF | ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2006-04-06 | — | — | WO | disclosed |
| CN-1006386-B | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | SHINETSU CHEM IND CO (JP) | 1990-01-10 | — | — | CN | disclosed |
| CN-85107531-A | Process for producing vinyl chloride polymer | — | 1987-01-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | CYBB, CBR3, AHR | APP 3729/4885NFE2L2 102/4885TRPA1 1407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.